Journal Watch · Nucleic Acids Research · 2026

Highly effective viral RdRP translocation hindrance by the remdesivir nucleotide.

Our work demonstrates translocation-related intervention as an effective and broadly applicable polymerase intervention strategy in NA rational design.

Li R, Shao Q, Wang M et al.Nucleic Acids Research3 min readPharma relevance 40/100

DOI: 10.1093/nar/gkag957PMID: 42895065Study type: research study

TL;DR

Our work demonstrates translocation-related intervention as an effective and broadly applicable polymerase intervention strategy in NA rational design.

Key findings

  • Nonetheless, the incorporated RDV nucleotide can still alter the free-energy landscape even in the S417G mutant complex, enabling the capture of an over-translocated state.
  • Our work demonstrates translocation-related intervention as an effective and broadly applicable polymerase intervention strategy in NA rational design.

Numbers at a glance (from the abstract)

100-fold

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

RDV is capable of inducing a characteristic "delayed" intervention, wherein the interference occurs several NACs after its incorporation. By combining X-ray crystallography, quench-flow kinetics, and molecular dynamics simulations, we show that the composite rate of RDV translocation from product strand position -3 to -4 and subsequent catalysis is at least 100-fold slower than that of adenosine in an enterovirus RdRP. However, mutating the corresponding roadblock residue serine417 to glycine largely abolishes this difference.

Full abstract (original)

Background: Nucleoside/nucleotide analogs (NAs) typically interfere with substrate selection and catalysis steps of polymerase nucleotide addition cycle (NAC), thereby affecting polymerase catalytic efficiency. In contrast, their interference with post-chemistry translocation is rarely considered in rational design, partly due to a lack of direct and quantitative evidence for such interference. Remdesivir (RDV) is an adenosine analog with broad-spectrum antiviral activity against diverse RNA virus families and has been approved for COVID-19 treatment.

What they did: RDV is capable of inducing a characteristic "delayed" intervention, wherein the interference occurs several NACs after its incorporation. By combining X-ray crystallography, quench-flow kinetics, and molecular dynamics simulations, we show that the composite rate of RDV translocation from product strand position -3 to -4 and subsequent catalysis is at least 100-fold slower than that of adenosine in an enterovirus RdRP. However, mutating the corresponding roadblock residue serine417 to glycine largely abolishes this difference.

Results & conclusions: Nonetheless, the incorporated RDV nucleotide can still alter the free-energy landscape even in the S417G mutant complex, enabling the capture of an over-translocated state. Our work demonstrates translocation-related intervention as an effective and broadly applicable polymerase intervention strategy in NA rational design.

Abstract © the authors / Nucleic Acids Research (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1093/nar/gkag957 · PubMed 42895065.

Why it matters for pharma & biotech

  • Relevant to Biology & Life Sciences teams tracking Nucleic Acids Research for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Nucleic Acids Research study find?

Our work demonstrates translocation-related intervention as an effective and broadly applicable polymerase intervention strategy in NA rational design.

What type of study is this?

It is a research study, published in Nucleic Acids Research in 2026. RDV is capable of inducing a characteristic "delayed" intervention, wherein the interference occurs several NACs after its incorporation.

Where can I read the original paper?

The original is at the publisher via DOI 10.1093/nar/gkag957. PubMed ID: 42895065. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Li R, Shao Q, Wang M et al.. Highly effective viral RdRP translocation hindrance by the remdesivir nucleotide.. Nucleic Acids Research (2026). DOI: 10.1093/nar/gkag957.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/highly-effective-viral-rdrp-translocation-hindrance-by-the-remdesivir-nu-kag957/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides